On a blank canvas, they draw the skeletal structure of the molecular compounds they want to make, and the platform uses machine learning to predict the ingredients required and the order in which they should be mixed.
The online platform lets scientists draw the skeletal structure of the molecular compounds they want to make.
It combines AI models, a cloud computing platform, and robots to help scientists design and synthesize new molecules while working from home.
IBM hopes that a platform like RoboRXN could dramatically speed up that process by predicting the recipes for compounds and automating experiments.
In theory, it would lower the costs of drug development and allow scientists to react faster to health crises like the current pandemic, in which social distancing requirements have caused slowdowns in lab work.
AI, robotics, and the cloud are allowing scientists to run chemistry experiments remotely.
AI, robotics, and the cloud are allowing scientists to run chemistry experiments remotely. https://t.co/hHNVSGcqIq— MIT Technology Review (@techreview) September 1, 2020